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Abstract 
Iron is reported to interact with other metals. In addition, it has been shown that genetic 
background may impact iron metabolism. Our objective was to characterize, in mice of three 
genetic backgrounds, the links between iron and several non-iron metals. Thirty normal mice 
(C57BL/6, Balb/c and DBA/2; n=10 for each group), fed with the same diet, were studied. 
Quantification of iron, zinc, cobalt, copper, manganese, magnesium and rubidium was 
performed by ICP/MS in plasma, erythrocytes, liver and spleen. Transferrin saturation was 
determined. Hepatic hepcidin1 mRNA level was evaluated by quantitative RT-PCR. As 
previously reported, iron parameters were modulated by genetic background with 
significantly higher values for plasma iron parameters and liver iron concentration in DBA/2 
and Balb/c strains. Hepatic hepcidin1 mRNA level was lower in DBA/2 mice. No iron 
parameter was correlated with hepcidin1 mRNA levels. Principal component analysis of the 
data obtained for non-iron metals indicated that metals parameters stratified the mice 
according to their genetic background. Plasma and tissue metals parameters that are 
dependent or independent of genetic background were identified. Moreover, relationships 
were found between plasma and tissue content of iron and some other metals parameters. 
Our data : i) confirms the impact of the genetic background on iron parameters, ii) shows that 
genetic background may also play a role in the metabolism of non-iron metals, iii) identifies 
links between iron and other metals parameters which may have implications in the 
understanding and, potentially, the modulation of iron metabolism. 
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Introduction 
Iron metabolism is finely tuned in order to ensure health and wellbeing (Andrews 
1999; Pollack et al. 1965). Disorders of iron metabolism include genetic iron overload, 
especially those related to the p.Cys282Tyr in the HFE gene. Bioclinical findings in HFE 
hemochromatosis show that the phenotypic presentation of the disease is variable. Indeed, 
whereas 3 per thousand persons exhibit homozygous mutation of HFE gene, and are 
therefore genetically predisposed, the disease expression spectrum may vary from the 
absence of iron metabolism abnormalities to the sole presence of transferrin saturation 
increase reflecting an abnormal recycling of iron, and to the development of visceral iron-
related complications with an impact on both quality of life and life expectancy (Brissot et 
al. 2008). Similarly, chronic inflammation occurring in many diseases may inconstantly 
impact iron metabolism (Weiss and Goodnough 2005), exposing patients to the risk of 
anaemia of chronic disease. 
In order to understand such differences, studies have been conducted to identify 
iron genes which could participate to this variability. Thus, other genes involved in iron 
metabolism have been identified, when mutated, in non-HFE genetic hemochromatosis 
(Camaschella et al. 2000; Papanikolaou et al. 2004; Roetto et al. 2003). In addition, 
mutations within these genes could play a role in the expression of HFE hemochromatosis 
(Island et al. 2009; Le Gac et al. 2004; Merryweather-Clarke et al. 2003; Milet et al. 2007) 
or other iron related diseases (An et al. 2012; Finberg et al. 2008; Finberg et al. 2011; Melis 
et al. 2008; Nai et al.). The role of polymorphisms in non-iron genes has also been evoked. 
In addition, differences of clinical expression between genders could be related to 
testosterone (Latour et al. 2014). In mice, regarding genetic background, variability of iron 
gene expression has been reported between different strains (Courselaud et al. 2004; 
Dupic et al. 2002). In addition, iron overload severity in Hfe-/- mice is modulated by genetic 
background (Coppin et al. 2007). However, to date, there is no clear explanation for such a 
variability in the phenotypic expression of iron-related diseases in humans. 
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The observation of iron-related diseases in patients with gene mutations associated 
to other metals raises the general issue of the impact of non-iron metals on iron 
metabolism. Thus, iron overload is observed in hereditary aceruloplasminemia (Harris et al. 
1995; Loreal et al. 2002), but also in acquired hypo-ceruloplasminemia associated with zinc 
exposure (Videt-Gibou et al. 2009). In both situations, the lack of ferroxidase activity of 
ceruloplasmin, which is dependent of copper, likely alters iron transport in plasma. 
Moreover, abnormalities of iron metabolism have been reported in presence of metabolic 
alterations related to non-iron metals such as cobalt and manganese (Garcia et al. 2007; 
Hansen et al. 2010; Simonsen et al. 2012).  
 The potential interaction between iron and non-iron metals is also emerging from 
the observation that DMT1 (SLC11A2 gene), which is involved in the crossing of iron 
toward membranes, was also reported to take in charge other divalent cations including: 
zinc (Zn2+), copper (Cu2+), nickel (Ni2+), cobalt (Co2+), cadmium (Cd2+), manganese (Mn2+) 
and lead (Pb2+) (Gunshin et al. 1997). Moreover, ferroportin, the exporter of iron from 
enterocytes and macrophages toward the plasma, could also export zinc and cobalt 
(Mitchell et al. 2014; Troadec et al. 2010). It has also been reported that the expression of 
hepcidin, the main controller of systemic iron metabolism, could be modulated by the metal 
responsive element- binding transcription factor-1 (MTF1) (Balesaria et al. 2010).  
  
Taken together, these elements suggest that interactions with non-iron metals may 
play a role in the control of normal, and abnormal, iron metabolism. Therefore, our goal 
was, by taking advantage of reported differences on iron metabolism between mice from 
different genetic backgrounds, to look whether other metals are also modulated by genetic 
background and to search for relationships between hepcidin, iron and non-iron metals. 
The study was conducted in DBA/2, C57BL/6, Balb/c wild-type mouse strains, and we 
characterized 6 metals, including : i) four transition metals Zn, Cu, Mn, Co which have been 
associated with iron metabolism in the literature; ii) Mg, an earth alkali metal cofactor of 
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numerous enzymes (Fawcett et al. 1999) and iii) Rb, an alkali metal, reported as a trace 
element having biological impact on behaviour (Carroll and Sharp 1971) and 
spermatogenesis (Yamaguchi et al. 2007), and being modulated by genetic background in 
mice (Siegers et al. 1977). Our data supports an impact of genetic background on the 
metabolism of non-ferrous metals, in addition to iron metabolism, and identifies links 
between iron and other metals parameters, related or not to genetic background. 
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Material and methods 
Animals 
The study was approved by the ethical Rennes committee for animal experimentation under 
the reference R-2012-0L-02. Four week-old C57BL/6J, Balb/cJ and DBA/2J mice were 
obtained from the Centre d’Elevage Robert Janvier (Le Genest St Isle, France) and housed 
in animal facilities (ARCHE) of UMS Biosit in Rennes. Thirty male mice (ten per group) were 
included. The environment was temperature and light-controlled. Mice were given free 
access to water and food (standard diet CRM-E from Special Diet Services®) over four 
weeks. All mice were studied at eight weeks, in the morning between 9 am and 12 am. Blood 
was obtained from a trans-diaphragmatic intracardiac puncture, and sampled in sodium 
heparin tubes suitable for trace element analysis. Mice were sacrificed and livers and 
spleens were dissected and weighed. Samples of liver and spleen were quickly frozen in 
liquid nitrogen, and then stored at -80°C to perform the measurement of trace elements 
concentrations and mRNA extractions. In addition, liver and spleen samples were also fixed 
in 4% buffered-formaldehyde for histological studies.  
 
Histological analysis 
After formaldehyde fixation, samples were paraffin embedded, and tissue sections 
(5µm) were performed. For histological evaluation of iron deposits, Perl’s staining and light 
microscopy evaluation were performed.  
 
Haemoglobin level determination 
Haemoglobin level was determined during the sacrifice on blood sample using 
HemoCue® 201+. 
Plasma iron parameters and plasma magnesium quantification 
Plasma iron and unsaturated iron-binding capacity (UIBC) were measured in the 
biochemistry laboratory (Rennes Hospital) on Cobas 8000 analyzer Roche® (Cobas® 
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reagents 03183696 122 and 04536355 190 respectively). Plasma transferrin saturation was 
then calculated as (plasma iron/(plasma iron + UIBC)) X100. 
 Plasma magnesium was measured on Cobas 8000 analyzer Roche® (Cobas® 
20737593 322). 
 
Trace elements 
Sample preparation: plasma, erythrocytes, liver and spleen 
All samples were handled with special care in order to avoid environmental 
contamination.  
After blood sample centrifugation, plasma was taken and frozen in polypropylene 
cryotubes at -80°C. Erythrocytes were then washed three times in NaCl 0,9% , centrifuged in 
NaCl 0,9% (3000g/min), and then were frozen in polypropylene cryotubes at -80°C.  
Livers and spleens samples were desiccated for 15 hours at 120°C. Then, dried 
samples were weighed and mineralized by nitric acid solution (Fisher Chemical – Optima 
Grade®) in special polypropylene tubes for 2 hours at 110°C in a heating block. Specimens 
were preserved at 4°C until quantification of metals. 
 
 Trace elements quantification 
Studied elements were: magnesium (24Mg), manganese (55Mn), iron (56Fe), cobalt 
(59Co), copper (63Cu), zinc (66Zn), and rubidium (85Rb). Trace elements were measured by 
ICP-MS (Inductively Coupled Plasma Mass Spectrometry), on a X-Series II from Thermo 
Scientific® equipped with collision cell technology (Platform AEM2, University of Rennes 1 / 
Biochemistry Laboratory, University Rennes Hospital). The source of plasma was argon 
(Messer®) with high degree of purity (>99.999%). The collision/reaction cell used was 
pressurized with a mixture of helium (93%) and hydrogen (7%) (Messer®). Ultrapure water 
was obtained from Millipore Direct-Q® 3 water station. Nitric acid solution was suprapur, at 
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69% (Fisher Chemical – Optima Grade®). Surfactant agent was used (Triton X-100 - 
Merck®). The internal standard used was rhodium (Fisher Scientific®). Calibration ranges 
preparation was carried out using a multi-element calibrator solution (SCP Science® Plasma 
Cal). Calibration and verification of instrument performance were realized using multi-
element solutions, respectively tune F and tune A (Thermo®). Certified reference materials 
and quality control were respectively obtained from NCS (bovine liver ZC71001) and Recipe 
(Clincheck plasma and whole blood controls for trace elements). 
 
Quantification of hepcidin 1 mRNA  
Expression of hepatic specific transcripts was analysed by quantitative RT-PCR. Total 
RNA from mouse liver was isolated using the SV Total RNA Isolation System (Promega®). 
RNA was then reverse transcribed into cDNA with the M-MLV reverse transcriptase 
(Promega®). The following primers have been used to amplify hepcidin 1 (Hepc1) (forward: 
5’-TTCCCAGTGTGGTATCTGTTGC-3’ and reverse: 5’-GGTCAGGATGTGGCTCTAGGC-3’), 
and HPRT (forward: 5’-TGTTCTAGTCCTGTGGCCATCT3’ and reverse: 5’-GCTCAT 
AGTGCAAATCAAAAGTCT-3’). Quantitative real-time PCR assays were performed in 96-
well microplates using the qPCR MasterMix Plus for SYBR® Green I (Eurogentec®) and the 
system StepOne Plus (Real-Time PCR System – Applied Biosystems®). All results were 
analysed by StepOne Software v2.1 (Applied Biosystem®). For each cDNA sample, the 
difference between the threshold cycle for Hepc1 amplification and the threshold cycle for 
HPRT was calculated. This allowed normalization of the amount of target to the endogenous 
reference, HPRT. 
Statistical analysis 
Results were expressed as mean +/- SD. Results obtained in the 3 strains were firstly 
compared by nonparametric Kruskall-Wallis test, followed when appropriate by a pair-wise 
comparison using nonparametric Mann-Whitney test. A p<0.05 was considered significant.   
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In order to get an overview of possible associations that could exist in different murine 
genetic backgrounds for trace elements and iron parameters, the results were explored by 
Principal Component Analysis (PCA). Analyses were performed with Factor MineR library 
(http://cran.r-project.org). PCA aims to simplify a dataset by reducing their dimensionality, 
while maintaining the maximum of information contained in these data. Thus, PCA provides 
graphical representations from the maximum of information in a data table. It allows the 
examination of the correlations between the variables (here the determined parameters) and 
to prioritize them according to their link to the principal components (PCs) (here the two PCs 
that capture maximum inertia highlight difference in the genetic backgrounds). 
Associations between parameters were assessed by univariate linear regression 
analysis. When the strain or the body weight was significantly associated with a parameter of 
interest, a multivariate linear regression analysis, including these variables, was performed. 
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Results 
Genetic background influences iron metabolism and non-iron metals 
Quantifications of trace elements - Co, Mn, Zn, Cu, Rb, Mg and Fe - were performed 
in plasma, liver, spleen and erythrocytes. In addition, plasma transferrin saturation, liver 
hepcidin 1 mRNA and haemoglobin levels were determined. Values obtained are 
summarized in Table 1 and schematic representation of the significant differences between 
the three strains is presented in Supplemental data S1. 
Briefly, regarding the impact of genetic background on each metal concentration: i) for 
Co, values were significantly different between strains in liver and erythrocytes ; ii) for Mn 
and Zn, significant differences appeared only in erythrocytes ; iii) for Cu, significant 
differences existed in plasma, liver and erythrocytes ; iv) it is noteworthy that, for Rb, 
significant differences were found in the four studied matrices ; v) for Mg, values in plasma, 
liver and spleen significantly differed between strains ; vi) for Fe, significant differences were 
found in plasma and liver; in addition, transferrin saturation and hepcidin 1 mRNA 
quantification were affected according to strains. 
Regarding the impact of strain on metal quantification in the different tissues: i) in 
erythrocytes, all metals, but Fe and Mg, were modulated ; ii) in the liver, all metals, but 
manganese and zinc, were affected ; iii) in plasma, Cu, Rb, Mg and Fe were modulated ; iv) 
in the spleen, only Rb and Mg were modulated. 
 
Global analysis of the impact of genetic background on metals  
We performed PCA to explore relationships existing between genetic backgrounds 
and metals concentrations, and particularly whether or not the three strains differed 
regarding the various studied biochemical parameters. 
The first principal component (PC 1) explains 22.7 % of parameters variability. PC 1 
primarily identifies differences between C57BL/6 mice and DBA/2 mice, but also reveals a 
stratification of all genetic backgrounds (Figure 1A). PC 2 likely represents inter-individual  
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Table 1. Trace elements and iron metabolism parameters concentrations in the four studied 
matrices in Balb/c, C57BL/6 and DBA/2 mice. 
 
Parameter Matrix C57BL/6 Balb/c DBA-2
C57BL/6       vs 
Balb/c
Balb/c vs  
DBA/2
C57BL/6 vs   
DBA-2
Plasma (µg/L) 4,2 ± 0,9 4,2 ± 0,7 4,9 ± 0,9 ns ns ns
Liver (µg/g) 0,21 ± 0,03 0,21 ± 0,02 0,16 ± 0,04 ns p<0,05 p<0,01
Spleen (µg/g) 0,06 ± 0,02 0,07 ± 0,03 0,1 ± 0,1 ns ns ns
Erythrocytes (µg/L) 0,65 ± 0,13 0,68 ± 0,06 0,81 ± 0,08 ns p<0,01 p<0,05
Plasma (µg/L) 2,4 ± 0,9 2,34 ± 0,63 2,19 ± 0,68 ns ns ns
Liver (µg/g) 4,1 ± 0,7 4,4 ± 0,7 4,4 ± 1 ns ns ns
Spleen (µg/g) 1,71 ± 0,72 1,37 ± 0,68 2,26 ± 2,25 ns ns ns
Erythrocytes (µg/L) 27,4 ± 4,6 20,3 ± 3,4 11 ± 1,4 p<0,01 p<0,001 p<0,001
Plasma (µg/L) 914 ± 117 861 ± 152 939 ± 192 ns ns ns
Liver (µg/g) 95 ± 40 110 ± 17 118 ± 48 ns ns ns
Spleen (µg/g) 91,4 ± 28,3 82,6 ± 16 112,5 ± 43,5 ns ns ns
Erythrocytes (µg/L) 5792 ± 775 6076 ± 656 6812 ± 357 ns p<0,01 p<0,01
Plasma (µg/L) 345 ± 26 426 ± 41 459 ± 61 p<0,001 ns p<0,001
Liver (µmol/g) 0,31 ± 0,05 0,43 ± 0,06 0,37 ± 0,03 p<0,001 p<0,05 p<0,01
Spleen (µmol/g) 0,14 ± 0,09 0,09 ± 0,02 0,11 ± 0,05 ns ns ns
Erythrocytes (µg/L) 431 ± 74 450 ± 50 507 ± 39 ns p<0,01 p<0,05
Plasma (µg/L) 204 ± 29 152 ± 30 133 ± 57 p<0,01 ns p<0,05
Liver (µg/g) 33,4 ± 1,5 31,4 ± 2,7 22,6 ± 1,6 p<0,05 p<0,001 p<0,001
Spleen (µg/g) 30,4 ± 2,9 28,1 ± 2 23,7 ± 1,7 p<0,05 p<0,001 p<0,001
Erythrocytes (µg/L) 5553 ± 1030 5025 ± 509 4005 ± 380 ns p<0,01 p<0,01
Plasma (mmol/l) 1,58 ± 0,13 1,34 ± 0,12 1,36 ± 0,19 p<0,01 ns p<0,05
Liver (mg/g) 0,76 ± 0,04 0,86 ± 0,03 0,78 ± 0,02 p<0,001 p<0,001 ns
Spleen (mg/g) 0,95 ± 0,05 0,89 ± 0,07 0,99 ± 0,04 ns p<0,01 p<0,05
Erythrocytes (µg/L) 46320 ± 8110 43498 ± 5655 46168 ± 5948 ns ns ns
Plasma (µmol/L) 26,9 ± 2,9 37,3 ± 5,8 41 ± 5 p<0,001 ns p<0,01
Liver (µmol/g) 4,6 ± 1,6 7,6 ± 1,6 7 ± 2,6 p<0,01 ns p<0,05
Spleen (µmol/g) 24,4 ± 3,6 26,7 ± 2,6 29,8 ± 17 ns ns ns
Erythrocytes (µg/L) 421300 ± 73740 464980 ± 41283 430860 ± 29259 ns ns ns
47,8 ± 6,6 63,3 ± 10 61,7 ± 9,2 p<0,01 ns p<0,01
64,4 ± 44,4 101,8 ± 43,1 36,9 ± 18,6 ns p<0,01 ns
12,3 ± 1 13,3 ± 0,8 12,1 ± 1,2 p<0,01 ns ns
Strain Strain comparison
Cobalt
Manganese
Zinc
Copper
Rubidium
Magnesium
Iron
Plasmatic transferrin saturation (%)
Liver hepcidin 1 mRNA (AU)
Haemoglobin (g/dL)  
Values are presented in the left part of the table as mean ± SD (Mean values are represented in bold). 
Statistically significant differences are presented in the right part of the table.  
AU: arbitrary unit. ns: non significant. 
 
 
variations. Vectors representing the most influential biochemical parameters which explain 
differences between strains, are presented in Fig. 1B. Iron parameters, including plasma 
iron, transferrin saturation and spleen iron are involved in the stratification. The Rb levels in 
the four studied matrices (plasma, liver, spleen and erythrocytes) play also an important role 
in the stratification. Cobalt and copper, mainly erythrocytes, plasma and liver concentrations, 
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are also involved, as well as the spleen and erythrocytes zinc and manganese 
concentrations. Variables playing a major role in the stratification according to axis 1 in PCA 
analysis are found in supplemental data S2. 
 
 
 
Links between metal parameters. 
Firstly, we identified by univariate linear regression analysis the metal parameters 
associated with a strain effect (Table 2). Thereafter, in each matrix, associations between all 
trace elements were studied through linear regression models. When univariate linear 
regression analysis led us to identify association between a parameter and the strain (Table 
2), a multivariate linear regression including the strain was performed. Results are 
schematically presented in Fig. 2.   
In plasma, associations were observed particularly between liver hepcidin 1 mRNA 
and Mn, and between transferrin saturation and copper. There was no relationship between 
plasma iron or transferrin saturation and hepcidin 1 mRNA level. In erythrocytes, an  
Figure 1. PCA analysis studying associations in different murine genetic backgrounds between 
trace elements and iron related parameters. A) Mapping of mice regarding the first two-dimensions 
(axis 1 and 2). Each mouse is represented by a dot: Balb/c mice in black, C57BL/6 mice in red and 
DBA/2 mice in green. The open squares represent the geometrical centroids for each strain. 
B) Representation of variables playing a major role in the stratification according to axis 1. 
 13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
association was observed between liver hepcidin 1 mRNA and haemoglobin levels. 
Moreover, a large number of associations were observed between the different trace 
elements. Finally, in liver and spleen, associations were noted mainly between Fe, Co and 
Mn, as well as between liver hepcidin 1 mRNA and Rb. 
 
 
 
Parameter p-value
Rb (liver) 4,3 10-12
Mn (erythrocytes) 2,7 10-10
Mg (liver) 1,7 10
-7
Rb (spleen) 1,9 10
-6
Fe (plasma) 2,8 10
-5
Cu (plasma) 4,1 10
-5
Cu (liver) 5,4 10
-5
Rb (erythrocytes) 1,4 10
-4
Co (erythrocytes) 9,6 10
-4
Hepcidin 1 mRNA (liver) 0,0024
Transferrin saturation 0,0028
Mg (plasma) 0,0029
Co (liver) 0,0029
Zn (erythrocytes) 0,0035
Mg (spleen) 0,0039
Rb (plasma) 0,0048
Fe (liver) 0,0064
Cu (erythrocytes) 0,0156
Haemoglobin 0,0229
Weight 0,0817
Co (plasma) 0,1033
Zn (spleen) 0,1263
Fe (erythrocytes) 0,1561
Cu (spleen) 0,2450
Co (spleen) 0,3964
Mn (spleen) 0,4057
Zn (liver) 0,4153
Fe (spleen) 0,5189
Zn (plasma) 0,5698
Mg (erythrocytes) 0,5742
Mn (liver) 0,5875
Mn (plasma) 0,8534
Table 2. Impact of the strain on trace elements and iron 
metabolism parameters. 
Presence of a strain effect was determined for each element in 
each matrix by univariate linear regression analysis. Elements 
with a strain effect are indicated with dark grey background, 
elements without strain effect with light grey background. 
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Figure 2. Schematic representation of the existing links between trace elements and iron 
parameters values in the 4 matrices. Relationships were studied for each element in each 
matrix. They were determined by univariate linear regression analysis, when the strain was 
demonstrated having no impact on the parameter, or by multivariate linear regression analysis, 
including strain, when an impact of genetic background was demonstrated. Parameters, for which 
a strain effect was determined, are indicated by *. Associations with a p-value <0,01 are indicated 
by a thick line, associations with a p-value between 0,05 and 0,01 by a thin line. Associations 
identified by multivariate linear regression analysis (p-value <0,05) but not found 
by univariate analysis, are indicated as dotted lines. Liver hepcidin 1 mRNA level, considered as a 
potential regulator of trace elements, has been integrated and taken into account in the four 
matrices. 
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Discussion 
The variable phenotypic features of iron-related diseases, including genetic iron 
overload, suggest that there are yet largely undetermined factors which modulate the 
disease clinical expression. Among potential factors, we hypothesized that interactions of 
iron metabolism with other metals could play a role. In a first approach we explored whether 
the modulation of iron metabolism existing between mice of three genetic backgrounds, was, 
or not, associated with modulation of non-iron metal parameters.  
  
As expected for iron parameters (Champy et al. 2008; Courselaud et al. 2004; Dupic 
et al. 2002; Leboeuf et al, 1995; Siegers et al. 1977; Wang et al. 2007), Balb/c and DBA/2 
mice presented significantly higher iron concentrations and transferrin saturation values in 
plasma and increased liver iron concentrations compared to C57BL/6 mice. These results 
confirm the impact of genetic background on systemic iron metabolism parameters in mice. 
This concept is also supported by data showing, in drosophila, that Fe concentration varies 
between species (Sadraie and Missirlis 2011). 
Looking for the relationships between the levels of hepatic hepcidin 1 mRNA, which 
encodes the gate keeper of iron parameters on the one hand, and plasma iron, transferrin 
saturation and tissue iron concentrations on the other hand, no statistically significant 
relationship was found. Moreover, DBA/2 mice showed significantly lower hepatic hepcidin 1 
mRNA levels than Balb/c mice, whereas the previously reported hepcidin 1 mRNA increase 
in C57BL/6 vs DBA/2 mice was not found (Coppin et al. 2007). Thus, in these wild type 
healthy mice, hepcidin levels were closed from one strain to another, despite significant 
differences in systemic iron parameters.  
These data suggest that, in normal healthy condition, physiological parameters, that 
are independent of iron metabolism, might subtly regulate hepcidin levels and intervene 
continuously, thus modulating the strength of the relationship between iron parameters and 
hepcidin expression as reported in iron -related disorders.  
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They may also support our hypothesis that other, not yet identified parameters, play a 
role in the control of hepcidin expression and/or iron parameters. Thus, non-iron metals, for 
which associations with iron metabolism and/or diseases have been reported (Loreal et al. 
2014), could participate to the modulation of iron parameters. The links between parameters 
of these metals, iron metabolism and genetic background have not yet been studied in mice. 
However, comparing concentrations, it has been reported that Zn, Cu and Mn concentrations 
may vary between Tephritidae (fruit flies) species fed with their regular diet. In addition those 
parameters can be changed by modification of regimen (Rempoulakis et al. 2014).  
We chose to investigate, in mice receiving the same diet, four metals, Cu, Zn, Mn and 
Co, for which associations with iron have been reported in human health, and two other (Mg 
and Rb), which exert potential biological functions and for which interactions with iron have 
not yet been evaluated. Thus, we found significant variations of metal concentrations which 
are likely only related to genetic background differences. In addition, when looking at the 
metal parameter levels in the four matrices of the three strains, the PCA analysis led us to 
stratify the strains. The largest difference was found between the C57BL/6 and the DBA/2 
strains. It is noteworthy that Fe was not the only metal participating to such stratification. On 
the one hand, one part of the trace elements in some matrices showed similar concentrations 
between the three mice strains. This observation suggests that these trace elements may 
obey a general and identical law for each mice strain. On the other hand, part of trace 
elements in some matrices showed significant differences between mice strains.  
Links between plasma concentrations of the different metals are difficult to interpret 
due to the fact that plasma metal concentrations are temporary conditions which vary due to 
digestive absorption, but also to different half-lives in the circulation, related to different 
modalities in tissue uptake and/or elimination. However, it is noteworthy that the only 
statistical link involving plasma transferrin saturation that we identified concerned plasma 
copper. Such a relationship was not surprising, knowing that the main copper-linked protein 
is ceruloplasmin, a multicopper oxidase that plays a major role, through its ferroxidase 
activity, in the interaction between ferric Fe and transferrin (Mukhopadhyay et al. 1998) 
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As to the erythrocytes, statistical relationships were found between all the studied 
metal parameters and are therefore difficult to interpret. A slight statistical link was observed 
between haemoglobin and hepatic hepcidin 1 mRNA level expression, suggesting that in 
normal condition tissue oxygenation level and/or erythropoietic activity could be critical 
factors in the balance of hepcidin expression. The recently reported erythroferrone factor 
(Kautz et al. 2014) could be involved. 
 
In the liver and spleen, correlations were found between the concentrations of some 
metals and iron in the corresponding tissue and/or hepatic hepcidin mRNA levels.  
Rb, a metal with antidepressant properties (Tuoni et al. 1987), strongly separates 
C57BL/6 and DBA/2 strains in PCA. Such differences in Rb parameters between strains 
have been previously suggested (Siegers et al. 1977). Moreover, the linear regression 
statistical analysis taking the strain into account supports the link between liver or spleen Rb 
concentrations and hepcidin1 mRNA levels. Quickly absorbed after oral ingestion, Rb is 
distributed throughout the body and eliminated in urine. The highest concentrations are found 
in liver and muscles (Meltzer 1991; Tuoni et al. 1987). Rb is taken up by cells through 
membrane channels shared with potassium, and this property is used to perform cardiac 
function evaluation by using radioactive 82Rb and positron emission tomography (Mc Ardle et 
al. 2012). The biologic half-life of Rb is close to 45 days. Chronic exposure to Rb may favour 
its body accumulation (A et al. 1977; Meltzer 1991). The link between Rb and hepcidin 
mRNA level warrants further investigation.  
Links were also found between Co and Fe concentrations in liver and spleen. Co 
exposure in humans results, mainly in developed countries, from prosthetic material in 
addition to oral ingestion as pollutant. It has been reported that DMT1 is able to take up Co 
as other divalent cations (Gunshin et al. 1997). Co, by stabilizing the transcriptional factor 
HIF (hypoxia-inducible factor), may mimic hypoxia and, in turn, stimulates adaptive response 
to hypoxia (Simonsen et al. 2012). Interactions between iron and Co have been described. It 
has been initially reported that digestive absorption of iron and Co was increased in rats with 
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iron deficiency (Pollack et al. 1965), in patients with hepatic steatosis complicated by iron 
deficiency and in subjects with iron deficiency, compared to a similar group with normal iron 
status (Olatunbosun et al. 1970). Digestive absorption of Co was also increased in patients 
with genetic hemochromatosis or liver cirrhosis complicated by iron overload (Olatunbosun et 
al. 1970). Therefore, Co interacts with iron metabolism.  
Relationships between Mn and Fe concentrations both in liver and spleen were also 
found. Mn is a metal which is implicated in enzymatic activities, especially those associated 
with Mn-SOD which are involved in defense mechanisms against reactive oxygen species 
(Macmillan-Crow and Cruthirds 2001). Mn is mainly absorbed from digestive lumen but may 
also be acquired by airway. The first hepatic passage is strongly involved in Mn elimination 
(Cotzias 1958; Papavasiliou et al. 1966). Hepatic dysfunction has been reported favoring 
encephalopathy related to Mn excess in brain (Butterworth 2013). As for cobalt, it has been 
reported that digestive absorption of Mn and iron was increased in rats with iron deficiency 
(Pollack et al. 1965). It is noteworthy that in Hfe-/- mice, a model of hemochromatosis, Mn 
excess was associated with the iron overload, thus strongly linking the two metals in an iron-
related disorder (Kim et al. 2013). Moreover, the data obtained in healthy animals indicates 
that these two metals are also associated in normal situations. 
 
In conclusion, the present data shows that genetic background strongly modulates 
metal parameters. Moreover, they indicate that links could exist between iron parameters 
and non-iron metals parameters. This suggests that modulation of non-iron metals may 
interfere with iron metabolism in health and diseases. Therefore, these data indicate that 
knowledge on iron metabolism will benefit from further studies on the relationships between 
iron and other metals, especially when considering the increasing exposure of individuals to 
various non-iron metals during occupational or personal life.   
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Supplemental data 
 
Parameter Organ Balb/c C57BL/6 DBA-2
Liver ↑ ↑ ↓
Erythrocytes ↓ ↓ ↑
Manganese Erythrocytes ↑ ↓
Zinc Erythrocytes ↓ ↓ ↑
Plasma ↑ ↓ ↑
Liver ↑ ↓
Erythrocytes ↓ ↓ ↑
Plasma ↓ ↑ ↓
Liver ↑ ↓
Spleen ↑ ↓
Erythrocytes ↑ ↑ ↓
Plasma ↓ ↑ ↓
Liver ↑ ↓ ↓
Spleen ↓ ↓ ↑
Plasma ↑ ↓ ↑
Liver ↑ ↓ ↑
↑ ↓ ↑
↑ ↓
↑ ↓
Liver hepcidin 1 mRNA
Haemoglobin
Cobalt
Copper
Rubidium
Magnesium
Iron
Plasmatic transferrin saturation
Figure S1. Schematic representation of the modulation of parameters for which a 
significant impact of genetic background in Balb/c, C57BL/6 and DBA/2 mice was 
identified (see Table 1). 
 26 
 
Parameter Dim.1
Cu (plasma) 0,7041
Fe (plasma) 0,6955
Zn (erythrocytes) 0,6903
Co (erythrocytes) 0,6764
Cu (erythrocytes) 0,5899
Mg (plasma) -0,5149
Rb (plasma) -0,5709
Rb (erythrocytes) -0,5728
Co (liver) -0,6204
Rb (spleen) -0,7950
Mn (erythrocytes) -0,7958
Rb (liver) -0,8885
Figure S2. Representation of variables playing a major role 
in the stratification according to axis 1 in PCA analysis. 
Positive values (dark grey background) represent parameters 
differentiating DBA/2 mice. Negative values (light grey 
background) represent parameters differentiating C57BL/6 mice.  
 
